APA (7th ed.) Citation

IJ, O., CJ, H., & JK, A. (2017). Post-Marketing Regulation of Medicines Withdrawn from the Market Because of Drug-Attributed Deaths: An Analysis of Justification. Drug safety, 40(5), 431. https://doi.org/10.1007/s40264-017-0515-4

Chicago Style (17th ed.) Citation

IJ, Onakpoya, Heneghan CJ, and Aronson JK. "Post-Marketing Regulation of Medicines Withdrawn from the Market Because of Drug-Attributed Deaths: An Analysis of Justification." Drug Safety 40, no. 5 (2017): 431. https://doi.org/10.1007/s40264-017-0515-4.

MLA (9th ed.) Citation

IJ, Onakpoya, et al. "Post-Marketing Regulation of Medicines Withdrawn from the Market Because of Drug-Attributed Deaths: An Analysis of Justification." Drug Safety, vol. 40, no. 5, 2017, p. 431, https://doi.org/10.1007/s40264-017-0515-4.